Presenters: Harold Harvey, MD; Richard Santen, MD; Paul Goss, MD; Andrea Manni, MD
Topics covered in this program include: new aromatase inhibitors; risks and benefits of adjuvant tamoxifen; potential prevention of breast cancer by hormonal therapies; optimal duration therapy with tamoxifen; post-menopausal estrogen replacement therapy.
|